Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Sujata Thakur, Rishika Dhapola, Phulen Sarma, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 1-17
Closed Access | Times Cited: 238
The promotion mechanism of prebiotics for probiotics: A review
Siyong You, Yuchen Ma, Bowen Yan, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 149
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 136
Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Tien-Wei Yu, Hsien‐Yuan Lane, Chieh‐Hsin Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8208-8208
Open Access | Times Cited: 127
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice
Jing Sun, Yuhe Zhang, Yu Kong, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 76-88
Open Access | Times Cited: 98
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 90
Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota
Ashwinipriyadarshini Megur, Eric Banan-Mwine Daliri, Daiva Baltriukienė, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6097-6097
Open Access | Times Cited: 80
Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases
Tanja Patricia Eicher, M. Hasan Mohajeri
Nutrients (2022) Vol. 14, Iss. 13, pp. 2661-2661
Open Access | Times Cited: 78
Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
Ana Gabriela Barros Peláez, Pablo Durán, Ivana Vera, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7499-7499
Open Access | Times Cited: 71
Anti-Inflammatory and Antioxidative Phytogenic Substances against Secret Killers in Poultry: Current Status and Prospects
Shereen Basiouni, Guillermo Téllez–Isaías, Juan D. Latorre, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 1, pp. 55-55
Open Access | Times Cited: 47
Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease
Licong Yang, Yabin Wang, Zhiwei Li, et al.
Carbohydrate Polymers (2023) Vol. 310, pp. 120714-120714
Closed Access | Times Cited: 46
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
James Melrose
Antioxidants (2023) Vol. 12, Iss. 3, pp. 663-663
Open Access | Times Cited: 42
Recent advances in the extraction, composition analysis and bioactivity of Camellia (Camellia oleifera Abel.) oil
Lu Gao, Lihua Jin, Qiannan Liu, et al.
Trends in Food Science & Technology (2023) Vol. 143, pp. 104211-104211
Closed Access | Times Cited: 42
The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing
Yuqing Liu, Yejun Tan, Zheyu Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Fecal microbiota transplantation attenuates Alzheimer’s disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation
Xiang Li, Qingyong Ding, Xinxin Wan, et al.
Behavioral and Brain Functions (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
The Role of Gut Microbiota and Gut–Brain Interplay in Selected Diseases of the Central Nervous System
Julia Doroszkiewicz, Magdalena Groblewska, Barbara Mroczko
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10028-10028
Open Access | Times Cited: 89
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress?
Vivek Sharma, Thakur Gurjeet Singh, Nikhil Garg, et al.
Biomolecules (2021) Vol. 11, Iss. 5, pp. 678-678
Open Access | Times Cited: 83
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Agata Mulak
Journal of Alzheimer s Disease (2021) Vol. 84, Iss. 2, pp. 461-477
Open Access | Times Cited: 68
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Félipe Esparza Salazar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1184-1184
Open Access | Times Cited: 61
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Doortje Dekens, Ulrich Eisel, Leonie Gouweleeuw, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101414-101414
Open Access | Times Cited: 57
Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: a cross-sectional analysis from the SILCODE study
Can Sheng, Kun Yang, Beiqi He, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer’s disease progression
Tushar Kanti Das, Bhanu Priya Ganesh
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations
L. Krishaa, Ted Kheng Siang Ng, Hai Ning Wee, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111787-111787
Open Access | Times Cited: 30
Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management
Linda Liang, Clarissa Saunders, Nerses Sanossian
Food Science & Nutrition (2023) Vol. 11, Iss. 4, pp. 1671-1704
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top